Multiple sclerosis is an inflammatory, demyelinating disease of the central nervous system (CNS) characterized by a wide range of clinical signs 1 . The location of lesions in the CNS is variable and is a crucial determinant of clinical outcome. Multiple sclerosis is believed to be mediated by myelin-specific T cells, but the mechanisms that determine where T cells initiate inflammation are unknown. Differences in lesion distribution have been linked to the HLA complex, suggesting that T cell specificity influences sites of inflammation 2 . We demonstrate that T cells that are specific for different myelin epitopes generate populations characterized by different T helper type 17 (T H 17) to T helper type 1 (T H 1) ratios depending on the functional avidity of interactions between TCR and peptide-MHC complexes. Notably, the T H 17:T H 1 ratio of infiltrating T cells determines where inflammation occurs in the CNS. Myelin-specific T cells infiltrate the meninges throughout the CNS, regardless of the T H 17:T H 1 ratio. However, T cell infiltration and inflammation in the brain parenchyma occurs only when T H 17 cells outnumber T H 1 cells and trigger a disproportionate increase in interleukin-17 expression in the brain. In contrast, T cells showing a wide range of T H 17:T H 1 ratios induce spinal cord parenchymal inflammation. These findings reveal critical differences in the regulation of inflammation in the brain and spinal cord.
Multiple sclerosis is an inflammatory, demyelinating disease of the central nervous system (CNS) characterized by a wide range of clinical signs 1 . The location of lesions in the CNS is variable and is a crucial determinant of clinical outcome. Multiple sclerosis is believed to be mediated by myelin-specific T cells, but the mechanisms that determine where T cells initiate inflammation are unknown. Differences in lesion distribution have been linked to the HLA complex, suggesting that T cell specificity influences sites of inflammation 2 . We demonstrate that T cells that are specific for different myelin epitopes generate populations characterized by different T helper type 17 (T H 17) to T helper type 1 (T H 1) ratios depending on the functional avidity of interactions between TCR and peptide-MHC complexes. Notably, the T H 17:T H 1 ratio of infiltrating T cells determines where inflammation occurs in the CNS. Myelin-specific T cells infiltrate the meninges throughout the CNS, regardless of the T H 17:T H 1 ratio. However, T cell infiltration and inflammation in the brain parenchyma occurs only when T H 17 cells outnumber T H 1 cells and trigger a disproportionate increase in interleukin-17 expression in the brain. In contrast, T cells showing a wide range of T H 17:T H 1 ratios induce spinal cord parenchymal inflammation. These findings reveal critical differences in the regulation of inflammation in the brain and spinal cord.
Experimental autoimmune encephalomyelitis (EAE) is an animal model that shows many similarities to multiple sclerosis 3 . However, rodent EAE differs from multiple sclerosis by manifesting as ascending flaccid paralysis, reflecting unexplained preferential targeting of inflammation to the spinal cord (described as classic EAE). In a small number of antigen-specific models, brain inflammation occurs (described as atypical EAE) [4] [5] [6] [7] [8] . Interferon-g (IFN-g) deficiency also causes certain myelin-specific T cells to preferentially induce brain inflammation 9, 10 . These studies raise the possibility that specific sites of inflammation in the CNS may reflect T cell specificity, as well as the ability to produce IFN-g. T H 1 cells secreting IFN-g were considered to be the primary mediators of EAE, but recent studies suggest that T H 17 cells show greater pathogenicity 11 . The roles of major histocompatibility complex (MHC) haplotype, T cell specificity and effector function in determining where inflammation occurs in the CNS are not well understood.
We investigated how the MHC locus influences CNS inflammation in MHC congenic C3H mice. C3H.SW (H-2 b ) mice that were immunized with recombinant rat myelin oligodendrocyte glycoprotein (rMOG) showed classic EAE, as described 12 . To our surprise, C3HeB/Fej (H-2 k ) mice suffered from severe, atypical EAE that was characterized by proprioception defects, ataxia, spasticity and hyperreflexivity (Fig. 1a) . Inflammatory cells infiltrated the spinal cord and optic nerve of both strains. However, inflammation in C3H.SW brains was primarily restricted to meninges, ventricles and vessels, whereas C3HeB/Fej brains were characterized by severe parenchymal infiltration of CD4 + T cells, macrophages and activated microglia (Fig. 1b) . Lesions in the cerebellar and periventricular white matter, brain stem, pons, fimbria hippocampi and cortex were consistently observed. The numbers of CD4 + , CD8 + , B220 + , Gr-1 + , CD11c + and F4/80 + cells were similar in the spinal cords of both strains, but were increased in C3HeB/Fej compared with C3H.SW brains (data not shown).
The gene encoding MOG lies in the MHC locus; however, no differences were found in its sequence or expression between C3H.SW and C3HeB/Fej mice ( Supplementary Fig. 1 online) . We therefore investigated the role of lymphocyte subsets in inducing brain inflammation in C3HeB/Fej mice, as their activity is MHC-allele dependent. rMOG-induced EAE in C3HeB/Fej B cell-deficient (mMT -/-), CD8 + T cell-deficient (B2m -/-) and CD8-depleted mice showed the same brain inflammation as wild-type mice. In contrast, EAE was completely abrogated by depleting CD4 + T cells (Supplementary Fig. 1 and Supplementary Table 1 online), demonstrating that CD4 + T cells are necessary and sufficient to induce brain inflammation.
Two CD4 + T cell epitopes, MOG 79-90 and MOG 97-114 , presented by I-E k and I-A k , respectively, were identified in C3HeB/Fej mice (Supplementary Fig. 2 Supplementary Fig. 2 ). To compare the encephalitogenic activities of epitope-specific T cells and eliminate any other genetic influences, we restimulated T cells from rMOGimmunized C3HeB/Fej Â C3H.SW (F1) mice with different peptides and transferred them separately into F1 recipients. MOG 35-55 -and MOG 79-90 -specific T cells induced only spinal cord inflammation that resulted in classic EAE, whereas MOG 97-114 -specific T cells induced brain, rather than spinal cord, inflammation that caused atypical EAE (Fig. 2a,b) . However, we detected no differences in either the processing of rMOG by brain versus spinal cord antigen-presenting cells (APCs) ( Supplementary Fig. 3 online) or the cell-surface expression of ESL-1, PSGL-1, LFA-1, VLA-4, CCR3, CCR5, CCR6, CCR9, CXCR3, CXCR4 and CXCR5 on epitope-specific T cells before transfer (data not shown).
To determine whether the effector function of MOG 97-114 -specific T cells differed from that of MOG 79-90 -or MOG 35-55 -specific T cells, we analyzed the number of epitope-specific T H 17 and T H 1 cells in mice with rMOG-induced EAE. The T H 17:T H 1 ratio was significantly higher for MOG 97-114 -specific T cells compared with the other specificities in spleen (P o 0.005) and CNS (P o 0.0005), owing to the fact that there were more IFN-g + MOG 79-90 -specific T cells and fewer interleukin-17 (IL-17) + MOG 35-55 -specific T cells when compared with MOG 97-114 -specific T cells ( Supplementary Fig. 4 online) . We investigated the influence of the T H 17:T H 1 ratio on lesion distribution in the CNS by adoptive transfer of rMOG-primed T cells that were skewed toward a T H 17 or T H 1 phenotype. Notably, MOG 35-55 -and MOG 79-90 -specific T cells that were skewed toward a T H 17 phenotype now induced predominantly atypical EAE, and MOG 97-114 -specific T cells that were skewed toward a T H 1 phenotype induced predominantly classic EAE (Fig. 2c) , indicating that T cell effector function influences the sites of inflammation. Consistent with the clinical presentation, T H 17-biased T cells recruited more inflammatory cells to the brain than were recruited by T H 1-biased T cells (Fig. 2d,e) .
To our surprise, despite preferential recruitment of inflammatory cells to the brain by T H 17-biased T cells, we did not observe preferential localization of the antigen-specific T H 17 cells themselves to the brain or spinal cord (Fig. 3a) . Furthermore, there was substantial overlap in the number of T H 17 cells in the brains of MOG 97-114 -and MOG 35-55 -specific T cell recipients with atypical EAE compared with classic EAE (Fig. 3b) , indicating that brain inflammation is not simply triggered by an increase in the absolute number of infiltrating antigen-specific T H 17 cells. Double-positive (IL-17 + IFN-g + ) T cells were not detected (o1%) in the CNS at disease onset (data not shown). However, a comparison of the T H 17:T H 1 ratios in the brain and spinal cord of recipients with atypical versus classic EAE revealed that all three T cell specificities induced atypical EAE only when the T H 17:T H 1 ratio in the brain was Z1. Conversely, classic EAE occurred when the T H 17:T H 1 ratio in the brain was r1 (Fig. 3c) . Together, these data indicate that the T H 17:T H 1 ratio in the brain, rather than the absolute number of T H 17 cells, is the key parameter for determining whether inflammation occurs in the brain. Because the antigen-specific T H 1 cell number was significantly higher in the spinal cord compared with the brain in IL-12-skewed recipients (P o 0.005; Fig. 3a) , we investigated whether the T H 17:T H 1 ratio also influences spinal cord inflammation. The range of T H 17:T H 1 ratios was the same for atypical EAE mice with and without tail paralysis, indicating that the ratio did not regulate spinal cord inflammation ( Supplementary Fig. 5 online) .
Because comparable numbers of antigen-specific T cells were detected in the brains of mice with classic and atypical EAE, we carried out immunohistochemical analyses to determine where T cells localized in the brain in the absence of inflammation. CD4 + T cells were largely confined to the meninges in the brain in classic EAE, even though they extensively infiltrated the spinal cord parenchyma of the same mice ( Supplementary Fig. 5 ), in stark contrast to the parenchymal infiltration of the brain by CD4 + T cells in atypical EAE (Fig. 2d) . These data suggest that a predominance of T H 1 cells exerts an inhibitory influence in the brain at the stage of parenchymal infiltration.
To investigate the mechanism by which the T H 17:T H 1 ratio regulates inflammation in the brain, we analyzed the expression of inflammatory genes in the brains and spinal cords of healthy mice and recipients of T H 1-or T H 17-biased MOG 97-114 T cells showing either Table 2 online and data not shown). Furthermore, both Foxp3 and CD25 were induced only in atypical EAE brains (Supplementary Table 2 ), indicating that T H 1 cells do not suppress inflammation in the brain by preferentially recruiting regulatory T cells. We found it interesting that some genes were induced comparably in the brains of mice with both atypical and classic EAE, demonstrating that T cell infiltration in the meninges induces some responses in classic EAE brains despite the lack of parenchymal inflammation. Notably, the expression of several genes was strongly increased in a brain-specific manner in atypical EAE. The expression of IL-17, CCL24, CCL11, CCL6 and MMP-12 was increased between five-and 26-fold in atypical compared with classic EAE brains, but differed no more than 2.5-fold in the spinal cords of both types of recipients (Supplementary Table 2) . IL-17 expression was particularly intriguing because it increased 25-fold in the brain compared with the spinal cord of mice with atypical EAE, but increased only 2.4-fold in the brain compared with the spinal cord in classic EAE mice. To determine whether the disproportionate increase in IL-17 expression in the brain in atypical EAE is responsible for triggering inflammation, we induced EAE by adoptively transferring T H 17-biased T cells and administering either neutralizing soluble IL-17 receptor or control IgG to the recipients. Although both groups had a 100% incidence of EAE, 8 out of 10 mice that received the IL-17-neutralizing reagent developed only classic EAE, and 9 out of 10 mice that received control IgG developed atypical EAE (Fig. 3d,e) . Consistent with the clinical phenotype, neutralization of IL-17 eliminated parenchymal inflammation in the brain, but not spinal cord, at EAE onset (Fig. 3f) . Neutralization of IL-17 reduced infiltration of neutrophils, but not CD4 + T cells or F4/80 + cells, in the spinal cord of mice with classic EAE (data not shown). Thus, enhanced IL-17 activity that occurs when T H 1 cells are not predominant in the infiltrating T cell population is required to trigger parenchymal inflammation in the brain, but not in the spinal cord.
The unique ability of non-skewed MOG 97-114 -specific T cells to induce brain inflammation suggested that MOG 97-114 -specific T cells intrinsically generate a higher T H 17:T H 1 ratio than the other specificities. Accordingly, the T H 17:T H 1 ratio for MOG 97-114 -specific T cells was significantly higher than that of the other specificities directly after immunization with rMOG, even though all T cells were primed under the same conditions in vivo (P o 0.05; Fig. 4a ). MOG 97-114 -specific T cells also showed a significantly higher functional avidity for their cognate antigen compared with MOG 35-55 -and MOG 79-90 -specific T cells (P o 0.005; Fig. 4b ), suggesting that the T H 17:T H 1 ratio may be influenced by functional avidity. This hypothesis was tested using T cells that were specific for myelin basic protein (MBP), MBP Ac1-11 , whose functional avidity for an analog peptide (MBP Ac1-11Met4Lys8 ) is increased approximately 1,000-fold compared with MBP Ac1-11 because of the increased affinity of the analog peptide for I-A u (Fig. 4c) . T cells primed in vivo with the high avidity MBP Ac1-11Met4Lys8 peptide showed significantly higher T H 17:T H 1 ratios than the same T cells primed with MBP Ac1-11 (P o 0.005; Fig. 4d ). Because the myelin-specific T cells were primed under identical conditions, with the cytokine milieu being the same, these results indicate that T cell functional avidity for pMHC is an independent determinant of T H 17:T H 1 ratios. Together our studies indicate that the T H 17:T H 1 ratio of infiltrating myelin-specific T cells, which is determined in part by epitope-specific T cell functional avidity, is a critical determinant of brain, but not of spinal cord, inflammation. T cells showing both high and low T H 17:T H 1 ratios initially infiltrate the brain and spinal cord meninges. However, at low T H 17:T H 1 ratios, T cell infiltration proceeded into the spinal cord, but not brain, parenchyma. Our data identify differential production of IL-17 in the brain when T cells are reactivated at high versus low T H 17:T H 1 ratios as the mechanism regulating infiltration into the brain parenchyma. We established a critical role for IL-17 in 
METHODS
Mice. C3HeB/Fej, C3.SW-H-2 b /SnJ (C3H.SW), C3.129P2(B6)-B2m tm1Unc /Dcr, B6.129S2-Igh-6 tm1Cgn /J, B10.PL(73 NS)/Sn, and C3H/Hej mice were purchased from the Jackson Laboratory and maintained in a specific pathogen-free facility at the University of Washington. MBP Ac1-11 T cell receptor (TCR) transgenic mice were previously described 27 . We backcrossed the B6.129S2-Igh-6 tm1Cgn /J mutation onto the C3HeB/Fej and C3H.SW background for 10-12 generations. The University of Washington Institutional Animal Care and Use Committee approved all procedures.
Proteins and peptides. We produced rMOG (rat MOG ) protein in Escherichia coli as described 28 . MOG peptides 35-55, 79-90, 97-114 (rat sequences) and MBP Ac1-11 (mouse sequence) were synthesized by Genemed, and MBP Ac1-11Met4Lys8 was synthesized at the California Institute of Technology, using Fmoc/HBTU chemistry. Peptides were purified to 99% purity.
EAE induction. We induced active EAE using 100 mg of rMOG and 200 ng of pertussis toxin (List Biological Laboratories) as described 29 Immunohistochemistry. We stained 7-mm frozen sagittal sections from perfused CNS tissue for CD4 (L3T4, BD Biosciences) and F4/80 (BM8, Invitrogen), and used either IgG-biotin (BD Biosciences), Vectastain (Vector) and 3,3¢-diaminobenzidine tetrahydrochloride (Sigma), or sAv-488 and rat 546-specific antibody (Molecular Probes) for detection. DAPI was included in some experiments to detect nuclei. For image analyses, we stained four sections per mouse, encompassing the spinal cord (lumbar, thoracic and cervical) and brain (brain stem, cerebellum, peri-ventricular region, cortex and olfactory bulb), for F4/80 and photographed lesions at 10Â using PixelLink digital-camera software. We analyzed the percent F4/80 + using IP Lab (Scanalytics). Because specific CNS regions targeted by inflammation varied in individual mice, we summed the percent F4/80 + for the three spinal cord regions and the five brain regions, and show averaged results for the recipients of each T cell specificity ± s.d.
Flow cytometry. We stained CNS mononuclear cells from perfused mice at EAE onset as described 30 , and carried out intracellular cytokine staining according to manufacturer's directions (BD Biosciences). We used antibodies to CD4 (L3T4), CD11c (HL3), Gr-1/Ly6G (1A8), IFN-g-FITC (XMG.1.2), IL-17-PE (TC11-18H10), CXCR5 (2G8) and CXCR4 (2B11) from BD Biosciences, F4/80 (RM2915) from Caltag, and CXCR3 (220803) and CCR9 (242503) from R&D Systems. Mouse chemokine-human IgG3 fusion proteins CCL19, CCL20, CCL22, and P-and E-selectin-human IgM fusion proteins were a gift from D. Campbell (Benaroya Research Institute) and were detected using human IgG-specific or human IgM-specific antibodies (Jackson ImmunoResearch).
Enzyme-linked immunosorbent spot. We plated splenocytes (2 Â Functional avidity. We incubated 1 Â 10 6 spleen and lymph node cells from rMOG-immunized mice with MOG peptides for 16-18 h, and detected responses by IFN-g and IL-17 ELISPOT. We determined the peptide dose eliciting 50% maximum response using the software program R (http://www. r-project.org) and the dose-response curve function. For MBP-specific T cells, we incubated splenocytes from MBP Ac1-11 -specific TCR transgenic mice with titrating doses of MBP Ac1-11 or MBP Ac1-11Met4Lys8 for 48 h and pulsed the cultures with 1 mCi [ 3 H] thymidine for 16-18 h.
